#Germany #Avista Healthcare #Munster #sanotact Group #Damier Group

Avista Healthcare Partners Acquires sanotact Group

In a strategic move aimed at expanding its portfolio in the consumer healthcare market, Avista Healthcare Partners has signed a definitive agreement to acquire sanotact Group GmbH, a well-established German firm specializing in vitamins, minerals, and supplements (VMS). This acquisition aligns with Avista's growth strategy in the healthcare sector, leveraging emerging trends around preventive health and consumer self-care.

Overview of the Acquisition

The agreement, announced on May 22, 2026, has also seen Damier Group join as a strategic co-investor, alongside existing investor FLOTTE Beteiligungen GmbH. This partnership emphasizes a reinvestment strategy for future growth, setting the stage for sanotact to amplify its operations and product offerings.

Headquartered in Münster, Germany, sanotact is renowned for its innovative approach to developing and commercializing VMS products. The company operates a comprehensive contract development and manufacturing organization (CDMO) platform and markets a diverse range of VMS brands, including its flagship line, sanotact®. Operating in 80 international markets, sanotact has established itself as a trusted partner in the health sector, known for its high-quality manufacturing.

Strategic Comments from Leadership

Avista's Chairman, Thompson Dean, expressed enthusiasm about the acquisition, stating, "sanotact represents a compelling opportunity to invest in a premier independent VMS platform in Europe. The Company is well-positioned to benefit from strong secular tailwinds, including the rising consumer focus on preventative health." Deane emphasized sanotact's unique capabilities and established market position as vital drivers for future growth.

Joining Dean in voicing support was Yvan Vindevogel, Founder of Damier Group, who noted that sanotact aligns perfectly with Damier's investment philosophy. Vindevogel cited the company's keen understanding of consumer health trends and the accelerating shift towards self-care, underscoring sanotact's strategic positioning for capturing market opportunities.

Martin Spengler, CEO of sanotact, also shared his excitement about the partnership, stating, "We are keen to work alongside Avista and Damier to build on sanotact's momentum. Their extensive healthcare expertise will support our innovation capabilities and expansion efforts.”

The Role of FLOTTE and Future Plans

Haymo Modelhart, Chairman of FLOTTE, emphasized the importance of finding partners who share a long-term vision for quality and customer relations. He expressed confidence that Avista and Damier were ideal partners to support sanotact's future growth trajectory.

Avista's track record in the consumer healthcare sector across North America and Europe made this partnership a natural step. This transaction marks the firm's ninth investment in the healthcare domain, reflecting their commitment to propelling growth-oriented businesses in the industry.

Conclusion

The acquisition is pending approval from regulatory authorities, but it positions Avista, Damier, and sanotact for a promising future. As health trends continue to evolve, the synergies from this partnership are expected to enhance innovation and increase market presence, further establishing sanotact as a leader in the global consumer health marketplace. For more information about Avista Healthcare Partners and sanotact, visit their respective websites.